These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11719372)

  • 1. Blockade of adenosine diphosphate receptors P2Y(12) and P2Y(1) is required to inhibit platelet aggregation in whole blood under flow.
    Turner NA; Moake JL; McIntire LV
    Blood; 2001 Dec; 98(12):3340-5. PubMed ID: 11719372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional significance of adenosine 5'-diphosphate receptor (P2Y(12)) in platelet activation initiated by binding of von Willebrand factor to platelet GP Ibalpha induced by conditions of high shear rate.
    Goto S; Tamura N; Eto K; Ikeda Y; Handa S
    Circulation; 2002 May; 105(21):2531-6. PubMed ID: 12034661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of inhibition of P2Y(1) and P2Y(12) on whole blood clotting, coagulum elasticity and fibrinolysis resistance studied with free oscillation rheometry.
    Ramström S; Rånby M; Lindahl TL
    Thromb Res; 2003 Mar; 109(5-6):315-22. PubMed ID: 12818256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
    Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
    Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity.
    Storey RF; Sanderson HM; White AE; May JA; Cameron KE; Heptinstall S
    Br J Haematol; 2000 Sep; 110(4):925-34. PubMed ID: 11054084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADP can induce aggregation of human platelets via both P2Y(1) and P(2T) receptors.
    Jarvis GE; Humphries RG; Robertson MJ; Leff P
    Br J Pharmacol; 2000 Jan; 129(2):275-82. PubMed ID: 10694233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the platelet P2Y12 receptor for adenosine diphosphate potentiates the antiplatelet effect of prostacyclin.
    Cattaneo M; Lecchi A
    J Thromb Haemost; 2007 Mar; 5(3):577-82. PubMed ID: 17155953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of ADP-induced intracellular Ca2+ responses and platelet aggregation by the P2Y12 receptor antagonists AR-C69931MX and clopidogrel is enhanced by prostaglandin E1.
    Fox SC; Behan MW; Heptinstall S
    Cell Calcium; 2004 Jan; 35(1):39-46. PubMed ID: 14670370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic Inhibition of Both P2Y1 and P2Y12 Adenosine Diphosphate Receptors As Novel Approach to Rapidly Attenuate Platelet-Mediated Thrombosis.
    Gremmel T; Yanachkov IB; Yanachkova MI; Wright GE; Wider J; Undyala VV; Michelson AD; Frelinger AL; Przyklenk K
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):501-9. PubMed ID: 26743169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of ADP receptor P2Y(12) in platelet adhesion and thrombus formation in flowing blood.
    Remijn JA; Wu YP; Jeninga EH; IJsseldijk MJ; van Willigen G; de Groot PG; Sixma JJ; Nurden AT; Nurden P
    Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):686-91. PubMed ID: 11950711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct roles of ADP receptors in von Willebrand factor-mediated platelet signaling and activation under high flow.
    Mazzucato M; Cozzi MR; Pradella P; Ruggeri ZM; De Marco L
    Blood; 2004 Nov; 104(10):3221-7. PubMed ID: 15284110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine derived from ADP can contribute to inhibition of platelet aggregation in the presence of a P2Y12 antagonist.
    Iyú D; Glenn JR; White AE; Fox SC; Heptinstall S
    Arterioscler Thromb Vasc Biol; 2011 Feb; 31(2):416-22. PubMed ID: 21106949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinolytic agents inhibit platelet adhesion onto collagen type I-coated surfaces at high blood flow conditions.
    Huang TC; Graham DA; Nelson LD; Alevriadou BR
    Blood Coagul Fibrinolysis; 1998 Apr; 9(3):213-26. PubMed ID: 9663703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relative importance of the ADP receptors, P2Y12 and P2Y1, in thrombin-induced platelet activation.
    Nylander S; Mattsson C; Ramström S; Lindahl TL
    Thromb Res; 2003; 111(1-2):65-73. PubMed ID: 14644082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets.
    Alevriadou BR; Moake JL; Turner NA; Ruggeri ZM; Folie BJ; Phillips MD; Schreiber AB; Hrinda ME; McIntire LV
    Blood; 1993 Mar; 81(5):1263-76. PubMed ID: 8443388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acyl derivatives of coenzyme A inhibit platelet function via antagonism at P2Y1 and P2Y12 receptors: a new finding that may influence the design of anti-thrombotic agents.
    Manolopoulos P; Glenn JR; Fox SC; May JA; Dovlatova NL; Tang SW; Thomas NR; Ralevic V; Heptinstall S
    Platelets; 2008 Mar; 19(2):134-45. PubMed ID: 18297551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ticlopidine on von Willebrand factor-mediated shear-induced platelet activation and aggregation.
    Goto S; Tamura N; Sakakibara M; Ikeda Y; Handa S
    Platelets; 2001 Nov; 12(7):406-14. PubMed ID: 11674857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of platelet sensitivity to inhibitors of COX-1, P2Y₁, and P2Y₁₂ using a whole blood microfluidic flow assay.
    Li R; Diamond SL
    Thromb Res; 2014 Feb; 133(2):203-10. PubMed ID: 24365044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shear-dependent functions of the interaction between soluble von Willebrand factor and platelet glycoprotein Ib in mural thrombus formation on a collagen surface.
    Sugimoto M; Tsuji S; Kuwahara M; Matsui H; Miyata S; Fujimura Y; Yoshioka A
    Int J Hematol; 1999 Jan; 69(1):48-53. PubMed ID: 10641443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors.
    Aslam M; Sedding D; Koshty A; Santoso S; Schulz R; Hamm C; Gündüz D
    Thromb Res; 2013 Nov; 132(5):548-57. PubMed ID: 24071464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.